Eu Ivdd Eu Ivd General On The Market ๐Ÿ‡ณ๐Ÿ‡ด Norway

Lyfstone Calprotectin (CLP) quantitative test

Calpro AS ยท ๐Ÿ‡ณ๐Ÿ‡ด Norway
Devices (same UDI-DI)
1
Certificates
0
Countries
16
Notified Bodies
0

Basic Information

Primary DI
07090082590059
Basic UDI-DI Code
B-07090082590059
Reference
LYFCLP005
Device Types
Single use
Regulation
Eu Ivdd
Classification
Eu Ivd General
Status
On The Market
Manufacturer
Calpro AS

Additional Description

The Lyfstoneยฎ Calprotectin for Synovial Fluid test is a method for risk strat- ification of infection in suspected periprosthetic joint infection (PJI) patients by determination of the calprotectin (CLP) level in human synovial fluid samples in combination with the dedicated Lyfstoneยฎ smartphone application. The test is intended as a diagnostic aid for screening of suspected PJI patients

CND Nomenclature Codes

Code Description
W01021199 RHEUMATOID / INFLAMMATORY DISEASE MARKERS - OTHER

Available In Countries

๐Ÿ‡ฆ๐Ÿ‡น Austria ๐Ÿ‡ง๐Ÿ‡ช Belgium ๐Ÿ‡ฉ๐Ÿ‡ช Germany ๐Ÿ‡ฌ๐Ÿ‡ท Greece ๐Ÿ‡ช๐Ÿ‡ธ Spain ๐Ÿ‡ซ๐Ÿ‡ท France ๐Ÿ‡ญ๐Ÿ‡บ Hungary ๐Ÿ‡ฎ๐Ÿ‡ช Ireland ๐Ÿ‡ฎ๐Ÿ‡น Italy ๐Ÿ‡ฑ๐Ÿ‡บ Luxembourg ๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands ๐Ÿ‡ณ๐Ÿ‡ด Norway ๐Ÿ‡ต๐Ÿ‡ฑ Poland ๐Ÿ‡ต๐Ÿ‡น Portugal ๐Ÿ‡ท๐Ÿ‡ด Romania ๐Ÿ‡ฌ๐Ÿ‡ง United Kingdom

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).

View all